1073|10000|Public
5|$|The {{effect on}} sexual desire is varied, with {{increase}} or decrease in some but with no effect in most. Combined oral contraceptives {{reduce the risk of}} ovarian cancer and endometrial cancer and do not change <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer.</b> They often reduce menstrual bleeding and painful menstruation cramps. The lower doses of estrogen released from the vaginal ring may reduce the risk of breast tenderness, nausea, and headache associated with higher dose estrogen products.|$|E
25|$|The American Cancer Society lists {{tamoxifen}} as a known carcinogen, {{stating that}} {{it increases the}} risk of some types of uterine cancer while lowering <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer</b> recurrence. The ACS states that its use should not be avoided in cases where <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer</b> recurrence without the drug is higher than the risk of developing uterine cancer with the drug.|$|E
25|$|High {{intake of}} citrus fruit has been {{associated}} with a 10% reduction in <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer.</b>|$|E
5000|$|Reduce <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> cancer: due to {{the weight}} loss from regular {{exercise}} may offer protection from breast cancer.|$|R
50|$|In 2011, the US Food and Drug Administration (FDA) {{reported}} that {{there was very little}} evidence to support the claim that green tea consumption may reduce <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> and prostate cancer.|$|R
50|$|In the UK, {{the tabloid}} press has {{reported}} on research claiming the 5:2 diet could reduce <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> cancer; however {{according to the}} NHS the evidence being considered formed an inadequate basis for making such statements.|$|R
25|$|However, {{not only}} sex hormones, but also insulin levels are {{positively}} associated with <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer.</b>|$|E
25|$|A {{new drug}} {{has been shown}} to reduce <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer</b> in post-menopausal women by 53 percent.|$|E
25|$|Fenretinide, a retinoid, is {{also being}} studied {{as a way to}} reduce <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer</b> (retinoids are drugs related to vitamin A).|$|E
30|$|Our {{objective}} was to disaggregate the large and heterogeneous “Asian” group to determine differences in <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> cancer-specific, cardiovascular and all-cause mortality among breast cancer survivors by API ethnicity. We further examined possible differences in mortality risk among API women born in the U.S. compared to non-U.S. born women.|$|R
40|$|In a study {{presented}} {{in this issue of}} the Journal, Zhang et al. (1) suggest that the effect of light alco-holic beverage consumption on <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> can-cer remains controversial. In 1994, I showed that <b>the</b> <b>risk</b> associated with, on average, one alcoholic drink daily (- 13 g of ethanol) was about 10 percent greater than that in nondrinkers in a combined analysis of the results of 38 studies (2). A relation of this size is like-ly to remain controversial because, in this instance, it is beyond the resolution of epidemiologic methods, as the possibility of confounding or other bias seems dif-ficult to exclude. Furthermore, with a true relative <b>risk</b> <b>of</b> that size, by chance alone some studies will appear unsupportive of an association and others supportive of a stronger association. <b>The</b> <b>risk</b> <b>of</b> <b>breast</b> cance...|$|R
40|$|In {{this issue}} of the Journal, Rebbeck et al. (1) have {{provided}} us with a meticulously executed, up-to-date meta-analysis that quantifies the reductions in <b>the</b> <b>risks</b> <b>of</b> <b>breast</b> and ovarian/fallopian tube can-cer that follow risk-reducing salpingo-oophorectomy (RRSO) in BRCA 1 and BRCA 2 (BRCA 1 / 2) mutation carriers. Their conclusion — “The summary risk reduction estimates presented here indicate that RRSO is strongly associated with reductions in <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> and ovarian/fallopian cancers, and should provide guidance to women in planning cancer risk reduction strategies ” — is fully supported by their analysis and will not surprise those who have followed the rapidly evolving management strategies for BRCA 1 / 2 mutation carriers. From our perspective, four features commend this study. First, the meta-analysis that forms the basis of these conclusions was carefully designed and thoughtfully implemented. The author...|$|R
25|$|Information on progesterone-only pills is less extensive, due {{to smaller}} {{sampling}} sizes, {{but they do}} not appear to significantly increase <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer.</b>|$|E
25|$|Dietary {{influences}} {{have been}} examined for decades with conflicting results and have so far failed to confirm any significant link. One recent study suggests that low-fat diets may significantly decrease <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer</b> {{as well as the}} recurrence of breast cancer.|$|E
25|$|The Susan G. Komen Breast Cancer Foundation {{awarded a}} $7.5 million grant to Penn State Hershey {{investigators}} {{to study the}} effect of a low dose of antiestrogen medications and omega-3 fatty acids on reducing high breast density, which can increase <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer.</b>|$|E
50|$|Breast changes like {{atypical}} ductal hyperplasia and lobular carcinoma in situ, {{found in}} benign breast conditions such as fibrocystic breast changes, are correlated with an increased breast cancer risk. Diabetes mellitus might also increase <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> cancer.Autoimmune diseases such as lupus erythematosus seem also to increase <b>the</b> <b>risk</b> for <b>the</b> acquisition <b>of</b> <b>breast</b> cancer.|$|R
40|$|Bibliography on phytoestrogens (plant estrogens) and <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> cancerBibliography on <b>the</b> <b>breast</b> cancer <b>risk</b> <b>of</b> phytoestrogens. Includes {{reviews and}} commentaries, human {{clinical}} and human epidemiologic studies, animal studies, in vitro studies, food composition references, and studies and commentaries on infant soy formula studies. United States Department of Agriculture CSREES, New York State Department of Health, and Cornell Universit...|$|R
40|$|Background: Results {{of several}} studies have {{suggested}} that diet during adolescence may influence <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> can-cer in adulthood. We evaluated whether an intervention to lower fat intake among adolescent girls altered their serum concentrations of sex hormones that, in adults, are related to breast cancer development. Methods: We conducted an an-cillary hormone study among 286 of the 301 girls who par...|$|R
25|$|Some genetic {{susceptibility}} {{may play a}} minor role in most cases. Overall, however, genetics {{is believed to be}} the primary cause of 5–10% of all cases. Women whose mother was diagnosed before 50 have an increased risk of 1.7 and those whose mother was diagnosed at age 50 or after has an increased risk of 1.4. In those with zero, one or two affected relatives, <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer</b> before the age of 80 is 7.8%, 13.3%, and 21.1% with a subsequent mortality from the disease of 2.3%, 4.2%, and 7.6% respectively. In those with a first degree relative with the disease <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer</b> between the age of 40 and 50 is double that of the general population.|$|E
25|$|HRT may be {{unsuitable}} for some women, including those {{at increased risk}} of cardiovascular disease, increased risk of thromboembolic disease (such as those with obesity or a history of venous thrombosis) or increased risk of some types of cancer. There is some concern that this treatment increases <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer.</b>|$|E
25|$|Weight loss after {{diagnosis}} has {{not been}} shown to decrease <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer</b> recurrence or mortality. However, physical activity after breast cancer diagnosis has shown some associations with reducing breast cancer recurrence and mortality independent of weight loss. Data for both weight loss and physical activity and the effect on breast cancer prognosis is still lacking.|$|E
40|$|Abstract Scope Intake {{of green}} tea may reduce <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> cancer; {{polyphenols}} in this drink can influence enzymes that metabolize estrogens, known causal factors {{in breast cancer}} etiology. Methods and results We examined the associations of green tea intake (Conclusions Findings suggest that intake of green tea may modify estrogen metabolism or conjugation {{and in this way}} may influence breast cancer risk. </p...|$|R
5000|$|Several type of {{preventive}} surgeries {{are known to}} substantially reduce cancer risk for women with high-risk BRCA mutations. [...] The surgeries may be used alone, in combination with each other, or in combination with non-surgical interventions to reduce <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> and ovarian cancer. Note that surgeries such as mastectomy and oophorectomy do not completely eliminate the chance <b>of</b> <b>breast</b> cancer; cases have reportedly emerged despite these procedures.|$|R
5000|$|... another 2014 review {{found no}} {{conflicting}} results {{in studies of}} dietary consumption <b>of</b> carotenoids and <b>the</b> <b>risk</b> <b>of</b> getting <b>breast</b> cancer ...|$|R
25|$|Diethylstilbestrol (DES) is a {{synthetic}} form of estrogen. It {{has been used}} between the early 1940s and 1971. Pregnant women took DES to prevent certain pregnancy complications. However, it also increased their risk of breast cancer. It also increased <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer</b> in the prenatally exposed daughters after they have reached an age 40 years.|$|E
25|$|Although the {{pesticide}} DDT was banned over 20 years ago, {{studies have shown}} that there are still trace amounts found in certain agricultural products, as well as in human and animal milk. While individual studies have come to conflicting conclusions, the most recent reviews of all the evidence conclude that exposure to DDT before puberty increases <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer</b> later in life.|$|E
25|$|It is {{not known}} whether {{prasterone}} is safe for long-term use. Some researchers believe prasterone supplements might actually raise <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer,</b> prostate cancer, heart disease, diabetes, and stroke. Prasterone may stimulate tumor growth in types of cancer that are sensitive to hormones, such as some types of breast, uterine, and prostate cancer. Prasterone may increase prostate swelling in men with benign prostatic hyperplasia (BPH), an enlarged prostate gland.|$|E
40|$|In {{the medical}} literature, {{the role of}} {{breastfeeding}} and reproductive factors in <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> carcinoma is still an open debate in premenopausal women. We highlight the role of breastfeeding and reproductive factors in luminal A and luminal B, the most frequent breast cancers. This case-control study analyzes a White premenopausal population <b>of</b> 286 <b>breast</b> cancer patients, divided into molecular subtypes, and 578 controls matched by age. Multivariate logistic regression models {{were used to assess}} the relationships of breastfeeding and other reproductive factors (age at menarche, parity, age at first pregnancy, number <b>of</b> children) with <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> cancers. Among <b>the</b> variables examined, reproductive factors did not alter <b>the</b> <b>risk</b> <b>of</b> cancer, whereas breastfeeding up to 12 months was a significant protective factor against luminal B breast cancer (multivariate odds ratio: 0. 22, 95 % confidence interval: 0. 09 - 0. 59, P= 0. 002). In contrast, luminal A cases did not significantly correlate with breastfeeding or other reproductive factors. Breastfeeding up to 12 months is strongly protective against the more aggressive luminal B, but not against the less aggressive luminal A breast cancer in premenopausal White women...|$|R
50|$|<b>The</b> {{relative}} <b>risk</b> <b>of</b> <b>breast</b> cancer {{based on}} a median follow-up of 8 years, in a case control study of US registered nurses, is 3.7.|$|R
5000|$|BRCA2 is {{associated}} primarily with post-menopausal <b>breast</b> cancer, although <b>the</b> <b>risk</b> <b>of</b> pre-menopausal <b>breast</b> cancer is significant. It is typically highly responsive to hormonal treatments.|$|R
25|$|The {{selective}} estrogen receptor modulators (such as tamoxifen) reduce <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer</b> but {{increase the}} risk of thromboembolism and endometrial cancer. There is no overall change in the risk of death. They are thus not recommended for the prevention of breast cancer in women at average risk but may be offered for those at high risk. The benefit of breast cancer reduction continues {{for at least five years}} after stopping a course of treatment with these medications.|$|E
25|$|Smoking tobacco {{appears to}} {{increase}} <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer,</b> with {{the greater the}} amount smoked and the earlier in life that smoking began, the higher the risk. In those who are long-term smokers, the risk is increased 35% to 50%. A lack of physical activity {{has been linked to}} about 10% of cases. Sitting regularly for prolonged periods is associated with higher mortality from breast cancer. The risk is not negated by regular exercise, though it is lowered.|$|E
25|$|There is an {{association}} between use of hormonal birth control {{and the development of}} premenopausal breast cancer, but whether oral contraceptives use may actually cause premenopausal breast cancer is a matter of debate. If there is indeed a link, the absolute effect is small. Additionally, it is not clear if the association exists with newer hormonal birth controls. In those with mutations in the breast cancer susceptibility genes BRCA1 or BRCA2, or who {{have a family history of}} breast cancer, use of modern oral contraceptives does not appear to affect <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> <b>cancer.</b>|$|E
30|$|There are six {{patients}} with family history <b>of</b> <b>breast</b> cancer among the total 71 breast cancer patients. These patients are categorized into <b>the</b> high <b>risk</b> <b>of</b> <b>breast</b> cancer group.|$|R
25|$|In early November 2012, Osbourne {{revealed}} she {{had undergone}} a double mastectomy after learning she had a gene that increases <b>the</b> <b>risk</b> <b>of</b> developing <b>breast</b> cancer.|$|R
5000|$|A high {{consumption}} of oxidized polyunsaturated fatty acids (PUFAs), which {{are found in}} most types of vegetable oil, may {{increase the likelihood that}} postmenopausal women will develop breast cancer. Similar effect was observed on prostate cancer, but the study was performed on mice. Another [...] "analysis suggested an inverse association between total polyunsaturated fatty acids and breast cancer risk, but individual polyunsaturated fatty acids behaved differently each other. ... a 20:2 derivative of linoleic acid ... was inversely associated with <b>the</b> <b>risk</b> <b>of</b> <b>breast</b> cancer".|$|R
